These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19244573)

  • 21. [Microalbuminuria: its pathophysiology, diagnostic significance and the methods of its study].
    Titov VN; Tarasov AV
    Ter Arkh; 1988; 60(6):134-40. PubMed ID: 3061047
    [No Abstract]   [Full Text] [Related]  

  • 22. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.
    Thomson SC; Vallon V; Blantz RC
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F8-15. PubMed ID: 14656757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
    Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nephropathy in type 1 diabetes mellitus. Current experimental and clinical aspects].
    Teschner M; Schaefer RM; Bahner U; Heidland A
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1730-4. PubMed ID: 1425285
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of fibrillin-1 in hypertensive and diabetic glomerular disease.
    Hartner A; Schaefer L; Porst M; Cordasic N; Gabriel A; Klanke B; Reinhardt DP; Hilgers KF
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1329-36. PubMed ID: 16380460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent advances concerning the pathogenesis of diabetic nephropathy].
    Scarpioni L
    Minerva Urol Nefrol; 1985; 37(1):5-8. PubMed ID: 3901336
    [No Abstract]   [Full Text] [Related]  

  • 27. The Endothelial Glycocalyx as a Key Mediator of Albumin Handling and the Development of Diabetic Nephropathy.
    Korakas E; Ikonomidis I; Markakis K; Raptis A; Dimitriadis G; Lambadiari V
    Curr Vasc Pharmacol; 2020; 18(6):619-631. PubMed ID: 31889495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of albuminuria and its clinical significance].
    Ratner MIa; Fedorova ND
    Klin Med (Mosk); 1986 Jun; 64(6):22-8. PubMed ID: 3528656
    [No Abstract]   [Full Text] [Related]  

  • 29. Microalbuminuria and normal protein filtration in the kidney.
    Shand B
    N Z Med J; 1987 Feb; 100(818):108-10. PubMed ID: 3470668
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diabetic nephropathy in children and adolescents].
    Dumas R
    Arch Pediatr; 1994 May; 1(5):455-7. PubMed ID: 7951828
    [No Abstract]   [Full Text] [Related]  

  • 31. [Microalbuminuria is a test for low molecular-weight biological impurities in the body's intercellular environment].
    Titov VN
    Klin Lab Diagn; 2007 Dec; (12):3-15. PubMed ID: 18228664
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats.
    O'Donnell MP; Kasiske BL; Daniels FX; Keane WF
    Diabetes; 1986 Sep; 35(9):1011-5. PubMed ID: 3743905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between Urinary Levels of Interleukin-6, Interleukin-10 and Tumor Necrosis Factor-Alpha with Glomerular and Tubular Damage Indicators in Patients with Type 2 Diabetes.
    Sangoi MB; Carvalho JAM; Guarda NS; Duarte T; Duarte MMMF; Premaor MO; Comim FV; Moretto MB; Moresco RN
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy.
    Holdaas H; Hartmann A; Berg KJ; Langberg H; Blystad L; Fauchald P
    J Intern Med; 1995 Jan; 237(1):63-71. PubMed ID: 7830033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease.
    Kikuchi K; Saigusa D; Kanemitsu Y; Matsumoto Y; Thanai P; Suzuki N; Mise K; Yamaguchi H; Nakamura T; Asaji K; Mukawa C; Tsukamoto H; Sato T; Oikawa Y; Iwasaki T; Oe Y; Tsukimi T; Fukuda NN; Ho HJ; Nanto-Hara F; Ogura J; Saito R; Nagao S; Ohsaki Y; Shimada S; Suzuki T; Toyohara T; Mishima E; Shima H; Akiyama Y; Akiyama Y; Ichijo M; Matsuhashi T; Matsuo A; Ogata Y; Yang CC; Suzuki C; Breeggemann MC; Heymann J; Shimizu M; Ogawa S; Takahashi N; Suzuki T; Owada Y; Kure S; Mano N; Soga T; Wada T; Kopp JB; Fukuda S; Hozawa A; Yamamoto M; Ito S; Wada J; Tomioka Y; Abe T
    Nat Commun; 2019 Apr; 10(1):1835. PubMed ID: 31015435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moving closer to an understanding of the hyperfiltration of type 2 diabetes mellitus.
    Wesson DE
    Am J Physiol Regul Integr Comp Physiol; 2006 Apr; 290(4):R973-4. PubMed ID: 16537822
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathogenesis of diabetic nephropathy.
    van Dijk C; Berl T
    Rev Endocr Metab Disord; 2004 Aug; 5(3):237-48. PubMed ID: 15211095
    [No Abstract]   [Full Text] [Related]  

  • 38. Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes.
    El Boustany R; Taveau C; Chollet C; Velho G; Bankir L; Alhenc-Gelas F; Roussel R; Bouby N
    J Diabetes Complications; 2017 Jun; 31(6):929-932. PubMed ID: 28412033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular function in diabetes mellitus.
    Brenner BM; Anderson S
    Adv Nephrol Necker Hosp; 1990; 19():135-44. PubMed ID: 2105577
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetic nephropathy: can the natural history be modified?
    Narins RG
    Am J Med; 1991 Feb; 90(2A):70S-75S. PubMed ID: 1994723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.